ACR 2024 | RheumNow

Nov 14-19, 2024

Topics

Day 4 Recap: ACR 2024

4 months 1 week ago

Evaluating ANA Patterns and Titers with AI

4 months 1 week ago

ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T

4 months 1 week ago

IVIG Treatment in Immune-mediated Necrotizing Myopathy

4 months 1 week ago

IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica

4 months 1 week ago

Can We Make Clinical Trials Better?

4 months 1 week ago

So really, are JAKs Safe?

4 months 1 week ago

The 2024 ACR Guidelines for Lupus Nephritis

4 months 1 week ago

Tackling the Workforce Crisis: A shared dilemma

4 months 1 week ago

Treatment Strategies in RA

4 months 1 week ago

Day 3 Recap: ACR 2024

4 months 1 week ago

The Real Value of JAKi is Beyond RA

4 months 1 week ago

Use of AI in Hand Ultrasound Scoring

4 months 1 week ago

Cumulative Steroid Use and Cardiovascular Events

4 months 1 week ago

axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure

4 months 1 week ago

Poster Hall

AbbVie March 2025

Sponsored by AbbVie Medical Affairs + Health Impact

Time to first musculoskeletal response of an IL-23i in PsA

Podcasts

Biomarkers in RA
Mar 31, 2025
Cancer Survival with TNF Inhibitors (3.28.2025)
Mar 27, 2025
ERA, APPs, & Alpha GAL (3.21.2025)
Mar 20, 2025

Catch up on Conference Podcasts

×